Original Article
Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function
N Engl J Med 2008; 358:1682-1691April 17, 2008
- Abstract
Background
The chitinase-like protein YKL-40 is involved in inflammation and tissue remodeling. We recently showed that serum YKL-40 levels were elevated in patients with asthma and were correlated with severity, thickening of the subepithelial basement membrane, and pulmonary function. We hypothesized that single-nucleotide polymorphisms (SNPs) that affect YKL-40 levels also influence asthma status and lung function.
Methods
We carried out a genomewide association study of serum YKL-40 levels in a founder population of European descent, the Hutterites, and then tested for an association between an implicated SNP and asthma and lung function. One associated variant was genotyped in a birth cohort at high risk for asthma, in which YKL-40 levels were measured from birth through 5 years of age, and in two populations of unrelated case patients of European descent with asthma and controls.
Results
A promoter SNP (−131C→G) in CHI3L1, the chitinase 3–like 1 gene encoding YKL-40, was associated with elevated serum YKL-40 levels (P=1.1×10−13), asthma (P=0.047), bronchial hyperresponsiveness (P=0.002), and measures of pulmonary function (P=0.046 to 0.002) in the Hutterites. The same SNP could be used to predict the presence of asthma in the two case–control populations (combined P=1.2×10−5) and serum YKL-40 levels at birth (in cord-blood specimens) through 5 years of age in the birth cohort (P=8.9×10−3 to 2.5×10−4).
Conclusions
CHI3L1 is a susceptibility gene for asthma, bronchial hyperresponsiveness, and reduced lung function, and elevated circulating YKL-40 levels are a biomarker for asthma and decline in lung function.
Media in This Article
Figure 1
Single-Nucleotide Polymorphisms (SNPs) in CHI3L1 and Its Upstream Region on Chromosome 1q32.1.Figure 2
Serum YKL-40 Level, Asthma Prevalence, and Lung-Function Measures in Hutterites, According to −131C→G Genotype (rs4950928).Article Activity
- Article
Chitinases are evolutionarily conserved proteins that mediate airway inflammation in mouse models of asthma.1 The chitinase-like protein YKL-40 lacks chitinase activity but binds ubiquitously expressed chitin and has been implicated in inflammation and tissue remodeling.2-6 We recently demonstrated that serum YKL-40 levels are elevated in patients with asthma and that circulating YKL-40 levels are correlated with asthma severity, thickness of the subepithelial basement membrane, and pulmonary function,7 suggesting that circulating YKL-40 levels are a biomarker for asthma. The YKL-40 protein is encoded by the chitinase 3–like 1 gene CHI3L1, and single-nucleotide polymorphisms (SNPs) in the CHI3L1 promoter have been associated with elevated serum YKL-40 levels,8,9 differential gene expression9 and transcript levels,10 and a higher risk of schizophrenia.9 We conducted a genomewide association study to identify genes that affect serum YKL-40 levels and hypothesized that variation in associated genes influences the risk of asthma and bronchial hyperresponsiveness and is associated with reduced lung function.
Methods
Written informed consent was provided by all adult participants; the children who participated provided oral assent and their parents provided written informed consent. The study was approved by the institutional review boards at the participating centers.
The Hutterites
To minimize the confounding effects of genetic and environmental heterogeneity, we focused our genetic studies of common diseases in the Hutterites.11,12 The 753 Hutterites we studied live on communal farms in South Dakota and are related to each other through multiple lines of descent in a 3028-person, 13-generation pedigree with 62 founders.13,14 The small number of founding genomes reduces genetic heterogeneity, and the communal lifestyle of the Hutterites ensures that nongenetic factors are remarkably uniform among persons. Smoking is prohibited (and rare) in this community, minimizing exposure to firsthand or secondhand smoke.
Asthma was assessed in 652 Hutterites by obtaining a history of symptoms (cough, wheeze, shortness of breath), bronchial hyperresponsiveness to methacholine inhalation or airway reversibility, and a doctor's diagnosis, according to previously published protocols.12,15 A total of 76 (11.7%) met the criteria for asthma; 80 others (12.3%) had bronchial hyperresponsiveness only, and 423 (64.9%) did not have bronchial hyperresponsiveness and were not symptomatic.12
Persons were considered to have atopy if they had a positive skin-prick test for at least 1 of 14 airborne allergens12; 311 of 702 Hutterites (44.3%) had atopy.
YKL-40 levels were measured in frozen serum specimens from 632 Hutterites who were 6 years of age or older.7 The clinical characteristics of these 632 Hutterites are shown in Table 1Table 1
Baseline Characteristics of the Hutterites with Measured YKL-40 Levels..For genetic studies, we used a natural-log transformation of the serum YKL-40 level to fulfill the distributional requirements of our methods, and we included age and sex as covariates. The heritability of YKL-40 levels was estimated with the use of variance-component methods.13,14 We used as a test of association the general two-allele model for quantitative measures (YKL-40 level, pulmonary-function measures, and total serum IgE level).16 (For more details of the variance component estimate of heritability, the general two-allele model test of association, and an estimate of the effect size of associated alleles on the trait variance, see the Supplementary Appendix, available with the full text of this article at www.nejm.org.)
Associations with binary phenotypes (asthma, bronchial hyperresponsiveness, and atopy) were assessed using the case–control quasi-likelihood test, which takes into account the relatedness between persons with the phenotypes and controls.17
The Childhood Origins of Asthma Cohort
The Childhood Origins of Asthma (COAST) cohort consists of 206 children of European descent (56.8% of whom are boys) who participated in genetic studies in a birth-cohort study of the origins of asthma,18 with asthma diagnosed at 6 years of age. Serum levels of YKL-40 were measured in 125 of these children at birth (in cord-blood specimens) and at 1 and 3 years of age and in 105 of these children at 5 years of age.
YKL-40 levels were measured in frozen serum specimens, according to the same protocols used for studies of the Hutterites.7 At 6 years of age, the children in the COAST cohort received a diagnosis of asthma if they met at least one of the following criteria: doctor-diagnosed asthma, use of doctor-prescribed albuterol for episodes of coughing or wheezing more than once between 60 and 72 months of age, daily use of controller medication, implementation of a step-up plan as prescribed by a doctor (including the use of albuterol or the short-term use of inhaled corticosteroids during illness), or use of doctor-prescribed prednisone for the treatment of an asthma exacerbation.
The difference in YKL-40 levels between children with asthma and those without asthma were tested using a Wilcoxon rank-sum test. Associations between CHI3L1 SNPs and YKL-40 levels were examined with the use of log-transformed YKL-40 levels at birth and at 1, 3, and 5 years of age in a linear-regression model, with sex included as a covariate.
Asthma Case Patients and Controls
Two populations of European descent were used to replicate the associations with asthma. The Freiburg population consists of 344 children with asthma and 294 control children without asthma, recruited from clinics at the Children's University Hospital in Freiburg, Germany. Asthma was defined by the presence of self-reported symptoms (cough, wheeze, or shortness of breath), current use of asthma medications, a doctor's diagnosis, and bronchial hyperresponsiveness (i.e., a 15% decrease in the baseline value of the forced expiratory volume in 1 second [FEV1] after either inhalation of ≤8 mg per deciliter of histamine or ≤6 minutes of exercise). The controls did not have a history of asthma, recurrent wheezing, or atopy. A total of 64.7% of the case patients were male, with a mean age of 10.1 years (range, 6 to 16) at the time of evaluation; 59.4% of the controls were male, with a mean age of 7.9 years (range, 4 to 16) at the time of enrollment.
The Chicago population consisted of 99 case patients recruited through the adult and pediatric asthma clinics at the University of Chicago Medical Center and 197 controls recruited from the same medical center. Diagnosis of asthma in the case patients was based on fulfillment of all of the following criteria: age of 6 or more years, presence of at least two of three symptoms (cough, wheeze, and shortness of breath), a physician's diagnosis of asthma (with no conflicting pulmonary diagnosis), either bronchial hyperresponsiveness (defined as a ≥20% decrease in FEV1 after inhalation of ≤25 mg of methacholine per milliliter) or an increase by 15% or more in FEV1 after treatment with a short-acting bronchodilator or treatment with inhaled corticosteroids, and less than 3 pack-years of cigarette smoking.15 The controls were adults recruited from the University of Chicago Medical Center who did not have a history of asthma (either personally or among first-degree relatives). In all, 32.5% of the case patients were male, with a mean age of 24.4 years (range, 7 to 74) at the time of evaluation; 52.5% of the controls were male, with a mean age of 31.6 years (range, 18 to 69) at the time of evaluation.
Associations with asthma were tested with the use of Fisher's exact test for differences in the genotypes and allele frequencies between case patients and controls. The 95% confidence intervals were obtained from the hypergeometric distribution of the entries, conditional on fixed margins. The analysis for the two case–control populations combined was done using the Cochran–Mantel–Haenszel method.
Genotyping and Quality Checks
We first carried out a genomewide association study to identify SNPs associated with serum YKL-40 levels (see the Supplementary Appendix). We then selected SNPs to tag all common haplotypes in CHI3L1 and within the 15 kb upstream of its transcriptional start site. We included in the analysis the validated nonsynonymous SNP rs880633, the functional promoter SNP rs4950928,9 and a SNP (rs946263) previously shown to be associated with levels of expression of CHI3L1.10 The tag SNPs rs4950928 (−131C→G), rs880633 (Arg145→Gly), rs10399805, rs1538372, and rs2275352 were genotyped using TaqMan Assay-on-Demand (ABI). An additional five SNPs in the 15-kb upstream region (including one tag SNP) were genotyped in specimens from the Hutterites, with the use of the Affymetrix GeneChip Mapping 500K Array; genotypes were determined by means of the BRLMM algorithm.19 Some redundant SNPs were included because they were present on the Affymetrix chip. The 10 SNPs were successfully genotyped in more than 95% of the persons studied, were in Hardy–Weinberg equilibrium (P>0.20), and in the Hutterites, had no mendelian errors (see the Supplementary Appendix). Allele frequencies and Hardy–Weinberg calculations for the Hutterites were adjusted for relatedness.20,21
Results
CHI3L1, YKL-40, and Asthma Phenotypes in the Hutterites
Serum YKL-40 levels increased significantly with increasing age in the Hutterites (Pearson's r=0.21, P<0.001) but did not differ between males and females (t=0.52, P=0.61). Mean YKL-40 levels were increased among Hutterites with asthma (102.7 ng per milliliter) or bronchial hyperresponsiveness (96.5 ng per milliliter), as compared with controls (87.2 ng per milliliter) (P=0.005 and P=0.002, respectively), but as in our previous study7 the levels did not differ between subjects with atopy (99.4 ng per milliliter) and those without atopy (85.1 ng per milliliter) (P=0.68). Among the Hutterites, serum YKL-40 levels were significantly inversely correlated with FEV1 (P=0.02) but not with forced vital capacity (FVC) (P=0.16), the FEV1:FVC ratio (P=0.98), or forced expiratory flow between 25% and 75% of the FVC (FEF25–75) (P=0.41).
To assess the relative contribution of genes to the variance in YKL-40 levels among subjects, we first estimated the heritability of the YKL-40 level. The narrow heritability (h2) of this trait in the Hutterites (±SE) is 0.51±0.10 and the broad heritability (H2) is 1.0±0.16. The high estimate for broad heritability indicates that differences in serum YKL-40 levels among individual Hutterites are due nearly entirely to genetic differences between individual persons. The comparatively large broad heritability indicates the presence of autosomal loci with significant nonadditive (e.g., dominant) effects on YKL-40 levels.
The most significant associations in the genomewide association study were found between the YKL-40 level and SNPs upstream of the gene encoding YKL-40, CHI3L1 (Figure S1 and S2 in the Supplementary Appendix). The P values for all tested SNPs calculated with the use of the general two-allele model can be obtained from the National Institutes of Health Genotype and Phenotype database, dbGaP (www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gap). To further evaluate the specific contribution of the CHI3L1 locus to the variance in YKL-40 levels, five additional SNPs were genotyped in the Hutterites; the location of these SNPs and the linkage-disequilibrium structure of the gene in this population are shown in Figure 1Figure 1
Single-Nucleotide Polymorphisms (SNPs) in CHI3L1 and Its Upstream Region on Chromosome 1q32.1.. Three SNPs on the Affymetrix chip (rs4950929, rs946263, and rs2153101) are in perfect linkage disequilibrium with the functional promoter SNP −131C→G (rs4950928) (r2=1.0) (Figure 1B, and Figure S3 in the Supplementary Appendix).These four SNPs showed the strongest association with serum YKL-40 levels of all the SNPs tested in the Hutterites (P≤1.3×10−12 for all four comparisons) (Table 2Table 2
Results of Association Studies of Single-Nucleotide Polymorphisms (SNPs) in the CHI3L1 Gene and Its Upstream Region on Chromosome 1q32.1 among the Hutterites.), and remained statistically significant after correction for the number of SNPs present on the Affymetrix chip (see the Supplementary Appendix). None of the 10 SNPs (Table 2) had significant sex-specific effects on serum YKL-40 levels. The nonsynonymous SNP in exon 5 (Arg145→Gly) was not significantly associated with YKL-40 levels (P=0.67) or any other phenotypic characteristic (Table 2). The major (most common) allele at each of the associated SNPs in CHI3L1 is the ancestral allele, according to the sequence of the orthologous gene in the chimpanzee. The −131C→G SNP rs4950928 accounts for 9.4% of the variance in YKL-40 levels in the Hutterites, with the minor G allele having an additive (negative) effect on YKL-40 levels (Figure 2AFigure 2Serum YKL-40 Level, Asthma Prevalence, and Lung-Function Measures in Hutterites, According to −131C→G Genotype (rs4950928).).In the Hutterites, the frequency of the rs4950928 C allele was 0.84 in persons with asthma, 0.83 in persons with bronchial hyperresponsiveness, and 0.79 in controls; the allele was significantly associated with the asthma phenotype (P=0.047 by the case–control quasi-likelihood test) and the bronchial hyperresponsiveness phenotype (P=0.002 by the case–control quasi-likelihood test) (Table 2 and Figure 2B). This SNP was not significantly associated with atopy (P=0.20 by the case–control quasi-likelihood test) or total serum IgE level (P=0.37 by the general two-allele model). The rs4950928 C allele was also a significant predictor of decreased FEV1 (P=0.046 by the general two-allele model), decreased FEV1:FVC (P=0.002 by the general two-allele model), and decreased FEF25–75 (P=0.03 by the general two-allele model) in the Hutterites (Table 2 and Figure 2C and 2D).
Replication Studies in the COAST Cohort
Serum YKL-40 levels were highest at birth and decreased through 3 years of age but were relatively stable between 3 and 5 years of age (Figure 3Figure 3
Mean Serum YKL-40 Levels in the Childhood Origins of Asthma Cohort, According to Age and −131C→G Genotype (rs4950928)., and Table S1 in the Supplementary Appendix). Serum YKL-40 levels at each age were not significant predictors of asthma diagnosis at 6 years of age, although the association at 3 years of age approached statistical significance (P=0.85 for the 121 subjects at birth, P=0.82 for the 121 subjects at 1 year of age, P=0.08 for the 121 subjects at 3 years of age, and P=0.29 for the 103 subjects at 5 years of age) (all P values by the Wilcoxon test).We also genotyped the −131C→G SNP (rs4950928) in the children in the COAST cohort. The −131C allele was associated with elevated YKL-40 levels at each age (Figure 3), indicating that genotype-specific effects on circulating YKL-40 levels are present at birth and remain throughout the first 5 years of life. The changes among ages within genotype groupings were not significant. Among the 178 children whose asthma status was evaluated at 6 years of age, 52 (29.2%) received a diagnosis of asthma. The −131C→G genotype and allele frequencies did not differ significantly between children with asthma and those without asthma at 6 years of age. This result could be due to the different criteria (based on clinical criteria) used to diagnose asthma in the children in the COAST cohort, the influence of the CHI3L1 SNPs on YKL-40 levels before the onset of asthma-related sequelae, or the SNP having an independent effect on the risk of asthma later in life (i.e., after age 6).
Replication Studies in the Case–Control Samples
In contrast to the COAST cohort, in the Freiburg population, the prevalence of the −131C allele was significantly greater in the case patients with asthma as compared with controls (frequency of the C allele, 0.81 among the case patients and 0.71 among the controls; P=1.6×10−4) (Table 3Table 3
The Single-Nucleotide Polymorphism −131C→G (rs4950928) in Case Patients with Asthma and Controls from Freiburg and Chicago.). In particular, the CC genotype was more common in patients with asthma (frequency, 0.66) than in controls (frequency, 0.51); both the CG and GG genotypes were more common among controls (CG frequency, 0.41 vs. 0.29 among the case patients; GG frequency, 0.08 vs. 0.05; P=5.6×10−4 by Fisher's exact test, assuming a dominant model). This pattern is similar to that found among the Hutterites. The odds ratio for the presence of one or two −131G alleles (CG or GG, vs. CC) was 0.54 (95% confidence interval [CI], 0.39 to 0.75), indicating that the minor −131G allele that is associated with reduced levels of circulating YKL-40 protein confers protection against asthma.A similar pattern of association was present in the smaller Chicago population, in which the −131G allele was overrepresented in the controls as compared to the case patients (P=0.11 by the Fisher's exact test; P=0.03 by Fisher's exact test, assuming a dominant model; odds ratio for the G allele, 0.56; 95% CI, 0.32 to 0.95) (Table 3). The odds ratio for the G allele (CG or GG, vs. CC) in the two populations combined was 0.54 (95% CI, 0.41 to 0.71) (P=1.2×10−5 by the Cochran–Mantel–Haenszel method).
Discussion
Our study shows that serum YKL-40 level is a highly heritable, quantitative trait in humans and confirms that YKL-40 level is a significant biomarker for asthma susceptibility and reduced lung function. Moreover, genetic variation in CHI3L1 influences serum YKL-40 levels and is associated with the risk of asthma, bronchial hyperresponsiveness, and reduced lung function. Although we cannot statistically distinguish between the implicated SNPs that are in perfect linkage disequilibrium, −131C→G SNP (rs4950928) seems likely to be the causal SNP; it is in the core promoter of CHI3L1, within a binding site for the MYC and MAX transcription factors. The minor allele (−131G on the forward strand) disrupts binding and was reported to be associated with reduced transcription in a luciferase reporter assay, lower messenger RNA levels in peripheral-blood cells, and reduced levels of circulating YKL-40 protein.9 Furthermore, a SNP in strong linkage disequilibrium with −131C→G (rs946263) was found to influence CHI3L1 transcript levels in a genomewide study of gene expression in cells from children with asthma.10 Our results are consistent with these findings and indicate that the −131G allele is protective against asthma and decline in lung function, that this effect is independent of allergic (atopic) pathways, and that the effect of this SNP on circulating levels of YKL-40 is present at birth.
Does the −131C→G SNP, or another SNP in strong linkage disequilibrium with −131C→G, directly influence the risk of asthma and decline in lung function, or are these phenotypic effects mediated through its effect on circulating levels of YKL-40? Our study and previous studies showing an association between serum YKL-40 levels and a number of inflammatory conditions,2,8 including asthma,7 or between SNPs in CHI3L1 and serum YKL-40 levels8,9 and gene expression,9,10 suggest that YKL-40 is an intermediate phenotype for asthma susceptibility. However, our results in the Hutterites and the COAST cohort do not allow us to reach this conclusion. For example, in the Hutterites, YKL-40 levels are not associated with the lung-function measures of FEV1:FVC and FEF25–75, yet the −131C→G SNP is a significant predictor of both (Table 2). In the COAST cohort, the −131C→G SNP is associated with YKL-40 levels at birth through 5 years of age but not with asthma at 6 years of age (Figure 3). Thus, the possibility remains that variation in CHI3L1 exerts effects on the risk of asthma and on lung function that are independent of circulating levels of YKL-40. Formal proof will require studying a larger population, with determinations of both serum YKL-40 levels and asthma status.
In summary, we identified an asthma susceptibility locus, CHI3L1, and showed that studying the genetics of quantitative traits (serum biomarkers) associated with asthma can identify asthma susceptibility loci. In the Hutterites, the CHI3L1 locus explains 9.4% of the variance in serum YKL-40 levels, suggesting that additional loci influence YKL-40 levels. Identifying the remaining loci that contribute to differences in serum YKL-40 levels and related proteins could identify additional genes with a significant effect on the risk of asthma and on lung function.
Supported by grants from the National Heart, Lung, and Blood Institute (HL85197, HL72414, HL56399, HL66533, and HL49596, to Dr. Ober; HL61879 and HL70831, to Dr. Lemanske; HL81638 and HL56389, to Dr. Elias; and M01 RR00055, to the University of Chicago Clinical Research Center).
Dr. Elias reports receiving grant support from MedImmune, a company exploring the regulation of YKL-40 as a therapy for asthma, and consulting fees from Eli Lilly, Pfizer, Promedior, MedImmune, Roche, and Millennium. A U.S. patent (no. 7, 214, 373) entitled “Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease” was issued on May 8, 2007, and is exclusively licensed to MedImmune (now owned by AstraZeneca); Dr. Elias is one of the inventors. Dr. Chupp reports receiving speakers' fees from GlaxoSmithKline, Merck, AstraZeneca, and Novartis and grant support from Wyeth, Centocor, Pfizer, and Novartis.
No other potential conflict of interest relevant to this article was reported.
Drs. Elias and Chupp contributed equally to this article.
This article (10.1056/NEJMoa0708801) was published at www.nejm.org on April 9, 2008.
We thank the Hutterites and the subjects in Chicago, Freiburg, and Madison for their participation in these studies and Kathy Roberg, Christopher Tisler, and Rebecca Anderson for technical support.
Source Information
From the University of Chicago, Chicago (C.O., Z.T., Y.S., L.P., R.N., S.R., L.A.L., D.L.N.); the University of Wisconsin, Madison (J.E.G., R.F.L.); Yale University School of Medicine, New Haven, CT (J.D.P., J.A.E., G.L.C.); the University of South Dakota Medical School, Sioux Falls (R.R.P.); and the University of Freiburg, Freiburg, Germany (A.H., K.A.D.).
Address reprint requests to Dr. Ober at the Department of Human Genetics, 920 E. 58th St., University of Chicago, Chicago, IL 60637, or at c-ober@genetics.uchicago.edu.
- References
References
1
Zhu Z ,Zheng T ,Homer RJ , et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004;304:1678-1682
CrossRef | Web of Science | Medline2
Johansen JS . Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006;53:172-209
Web of Science | Medline3
Johansen JS ,Jensen HS ,Price PA . A new biochemical marker for joint injury: analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-955
CrossRef | Medline4
Johansen JS ,Williamson MK ,Rice JS ,Price PA . Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992;7:501-512
CrossRef | Web of Science | Medline5
Hakala BE ,White C ,Recklies AD . Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-25810
Web of Science | Medline6
Kelleher TB ,Mehta SH ,Bhaskar R , et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 2005;43:78-84
CrossRef | Web of Science | Medline7
Chupp GL ,Lee CG ,Jarjour N , et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007;357:2016-2027
Full Text | Web of Science | Medline8
Kruit A ,Grutters JC ,Ruven HJ ,van Moorsel CC ,van den Bosch JMA . CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 2007;101:1563-1571
CrossRef | Web of Science | Medline9
Zhao X ,Tang R ,Gao B , et al. Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 2007;80:12-18
CrossRef | Web of Science | Medline10
Dixon AL ,Liang L ,Moffatt MF , et al. A genome-wide association study of global gene expression. Nat Genet 2007;39:1202-1207
CrossRef | Web of Science | Medline11
Ober C ,Abney M ,McPeek MS . The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001;69:1068-1079[Erratum, Am J Hum Genet 2002;70:284.]
CrossRef | Web of Science | Medline12
Ober C ,Tsalenko A ,Parry R ,Cox NJ . A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000;67:1154-1162
Web of Science | Medline13
Abney M ,McPeek MS ,Ober C . Broad and narrow heritabilities of quantitative traits in a founder population. Am J Hum Genet 2001;68:1302-1307
CrossRef | Web of Science | Medline14
Pan L ,Ober C ,Abney M . Heritability estimation of sex-specific effects on human quantitative traits. Genet Epidemiol 2007;31:338-347
CrossRef | Web of Science | Medline15
Lester LA ,Rich SS ,Blumenthal MN , et al. Ethnic differences in asthma and associated phenotypes: Collaborative Study on the Genetics of Asthma. J Allergy Clin Immunol 2001;108:357-362
CrossRef | Web of Science | Medline16
Abney M ,Ober C ,McPeek MS . Quantitative trait homozygosity and association mapping and empirical genomewide significance in large, complex pedigrees: fasting serum-insulin level in the Hutterites. Am J Hum Genet 2002;70:920-934
CrossRef | Web of Science | Medline17
Bourgain C ,Hoffjan S ,Nicolae R , et al. Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus. Am J Hum Genet 2003;73:612-626
CrossRef | Web of Science | Medline18
Lemanske RF Jr . The Childhood Origins of Asthma (COAST) study. Pediatr Allergy Immunol 2002;13:Suppl 15:38-43
CrossRef | Web of Science | Medline19
Rabbee N ,Speed TP . A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 2006;22:7-12
CrossRef | Web of Science | Medline20
Bourgain C ,Abney M ,Schneider D ,Ober C ,McPeek MS . Testing for Hardy-Weinberg equilibrium in samples with related individuals. Genetics 2004;168:2349-2361
CrossRef | Web of Science | Medline21
McPeek MS ,Wu X ,Ober C . Best linear unbiased allele-frequency estimation in complex pedigrees. Biometrics 2004;60:359-367
CrossRef | Web of Science | Medline
- Citing Articles (110)
Citing Articles
1
Hak-Ryul Kim, Chang-Duk Jun, Koung-Sun Lee, Ji-Hyun Cho, Eun-Taik Jeong, Sei-Hoon Yang, Young-Jin Lee, Do-Sim Park. (2012) Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease. Cytokine 58:3, 336-343
CrossRef2
Dominique J. Verlaan, Manon Ouimet, Veronique Adoue, Dave Sirois-Gagnon, Mathieu Larivière, Bing Ge, Patrick Beaulieu, Joana Dias, Kevin C.L. Lam, Vonda Koka, Catherine Laprise, Tomi Pastinen, Daniel Sinnett. (2012) Promoter polymorphisms in CHI3L1 are associated with asthma. Journal of Allergy and Clinical Immunology
CrossRef3
Hidenaga Yamamori, Ryota Hashimoto, Kazutaka Ohi, Yuka Yasuda, Motoyuki Fukumoto, Emiko Kasahara, Atsuo Sekiyama, Satomi Umeda-Yano, Takeya Okada, Masao Iwase, Hiroaki Kazui, Akira Ito, Masatoshi Takeda. (2012) A promoter variant in the chitinase 3-like 1 gene is associated with serum YKL-40 level and personality trait. Neuroscience Letters 513:2, 204-208
CrossRef4
Mi Na Kim, Kyung Eun Lee, Jung Yeon Hong, Won Il Heo, Kyung Won Kim, Kyu Earn Kim, Myung Hyun Sohn. (2012) Involvement of the MAPK and PI3K pathways in chitinase 3-like 1-regulated hyperoxia-induced airway epithelial cell death. Biochemical and Biophysical Research Communications
CrossRef5
Lisbeth Venø Kruse, Mette Nyegaard, Ulla Christensen, Steffen Møller-Larsen, Annette Haagerup, Mette Deleuran, Lars Gudmund Hansen, Stine Krogh Venø, Dirk Goossens, Jurgen Del-Favero, Anders Dupont Børglum. (2012) A genome-wide search for linkage to allergic rhinitis in Danish sib-pair families. European Journal of Human Genetics
CrossRef6
Lawrence H. Uricchio, Jessica X. Chong, Kevin D. Ross, Carole Ober, Dan L. Nicolae. (2012) Accurate Imputation of Rare and Common Variants in a Founder Population From a Small Number of Sequenced Individuals. Genetic Epidemiologyn/a-n/a
CrossRef7
Alan P. Knutsen, Robert K. Bush, Jeffrey G. Demain, David W. Denning, Anupma Dixit, Abbie Fairs, Paul A. Greenberger, Barbara Kariuki, Hirohito Kita, Viswanath P. Kurup, Richard B. Moss, Robert M. Niven, Catherine H. Pashley, Raymond G. Slavin, Hari M. Vijay, Andrew J. Wardlaw. (2012) Fungi and allergic lower respiratory tract diseases. Journal of Allergy and Clinical Immunology 129:2, 280-291
CrossRef8
Malcolm Nolan Blumenthal. (2012) Genetic, epigenetic, and environmental factors in asthma and allergy. Annals of Allergy, Asthma & Immunology 108:2, 69-73
CrossRef9
Dara G. Torgerson, Daniel Capurso, Rasika A. Mathias, Penelope E. Graves, Ryan D. Hernandez, Terri H. Beaty, Eugene R. Bleecker, Benjamin A. Raby, Deborah A. Meyers, Kathleen C. Barnes, Scott T. Weiss, Fernando D. Martinez, Dan L. Nicolae, Carole Ober. (2012) Resequencing Candidate Genes Implicates Rare Variants in Asthma Susceptibility. The American Journal of Human Genetics 90:2, 273-281
CrossRef10
Audrey H. Poon, David H. Eidelman, James G. Martin, Catherine Laprise, Qutayba Hamid. (2012) Pathogenesis of Severe Asthma. Clinical & Experimental Allergyn/a-n/a
CrossRef11
D. A. Cusanovich, C. Billstrand, X. Zhou, C. Chavarria, S. De Leon, K. Michelini, A. A. Pai, C. Ober, Y. Gilad. (2012) The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes. Human Molecular Genetics
CrossRef12
Youming Zhang, Miriam F. Moffatt, William O.C. Cookson. (2012) Genetic and genomic approaches to asthma. Current Opinion in Pulmonary Medicine 18:1, 6-13
CrossRef13
Dafna Bonneh-Barkay, Stephanie J. Bissel, Julia Kofler, Adam Starkey, Guoji Wang, Clayton A. Wiley. (2012) Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation. Brain Pathologyno-no
CrossRef14
Eleni Tsitsiou, Andrew E. Williams, Sterghios A. Moschos, Ketan Patel, Christos Rossios, Xiaoying Jiang, Oona-Delpuech Adams, Patricia Macedo, Richard Booton, David Gibeon, Kian Fan Chung, Mark A. Lindsay. (2012) Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma. Journal of Allergy and Clinical Immunology 129:1, 95-103
CrossRef15
Do-Sim Park, Young-Jin Lee, Joon Lim, Sang-Woo Yoo, Gi-Sung Nam, Jae-Hoon Lee. (2012) The Usefulness as a Specific Marker of Blood and Nasal Lavage Fluid YKL-40 in Allergic Rhinitis Patients. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 55:3, 161
CrossRef16
Saffron A. Willis-Owen, Miriam F. Moffatt. 2012. Basic Genetics and Epigenetics of Childhood Lung Disease. , 14-22.
CrossRef17
F. Aminuddin, L. Akhabir, D. Stefanowicz, P. D. Paré, J. E. Connett, N. R. Anthonisen, J. V. Fahy, M. A. Seibold, E. G. Burchard, C. Eng, A. Gulsvik, P. Bakke, M. H. Cho, A. Litonjua, D. A. Lomas, W. H. Anderson, T. H. Beaty, J. D. Crapo, E. K. Silverman, A. J. Sandford. (2011) Genetic association between human chitinases and lung function in COPD. Human Genetics
CrossRef18
C. E. Brightling, S. Gupta, S. Gonem, S. Siddiqui. (2011) Lung damage and airway remodelling in severe asthma. Clinical & Experimental Allergyn/a-n/a
CrossRef19
Robert J. Fontana, Heather J. Litman, Jules L. Dienstag, Herbert L. Bonkovsky, Grace Su, Richard K. Sterling, Anna S. Lok, . (2011) YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C. Liver Internationaln/a-n/a
CrossRef20
Jessica X Chong, A Afşin Oktay, Zunyan Dai, Kathryn J Swoboda, Thomas W Prior, Carole Ober. (2011) A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites. European Journal of Human Genetics 19:10, 1045-1051
CrossRef21
Yasutomo Imai, Tatsuya Tsuda, Seiko Aochi, Shizue Futatsugi-Yumikura, Yoshiko Sakaguchi, Noboru Nakagawa, Keiji Iwatsuki, Kiyofumi Yamanishi. (2011) YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis. Journal of Dermatological Science 64:1, 75-77
CrossRef22
Krzysztof Specjalski, Ewa Jassem. (2011) YKL-40 Protein is a Marker of Asthma. Journal of Asthma 48:8, 767-772
CrossRef23
Caroline A. Motika, Charalampos Papachristou, Mark Abney, Lucille A. Lester, Carole Ober. (2011) Rising prevalence of asthma is sex-specific in a US farming population. Journal of Allergy and Clinical Immunology 128:4, 774-779
CrossRef24
D. L. Goldman, X. Li, K. Tsirilakis, C. Andrade, A. Casadevall, A. G. Vicencio. (2011) Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children. Clinical & Experimental Allergyn/a-n/a
CrossRef25
Chun-Chuan Chen, Victoria Llado, Katrin Eurich, Hoa T. Tran, Emiko Mizoguchi. (2011) Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clinical Immunology 140:3, 268-275
CrossRef26
Ann Houston Williams, James Travis Smith, Edward E. Hudgens, Scott Rhoney, Halûk Özkaynak, Robert G. Hamilton, Jane E Gallagher. (2011) Allergens in Household Dust and Serological Indicators of Atopy and Sensitization in Detroit Children with History-Based Evidence of Asthma. Journal of Asthma 48:7, 674-684
CrossRef27
Anne Mette Mørup, Brian Kornblit, Julia S. Johansen, Tania Nicole Masmas, Hans O. Madsen, Lars Vindeløv, Peter Garred. (2011) The Prognostic Value of YKL-40 Concentrations in Nonmyeloablative Conditioning Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 17:9, 1299-1307
CrossRef28
Kenji Izuhara, Shoichiro Ohta, Hiroshi Shiraishi, Shoichi Suzuki. 2011. Interleukin 4, Interleukin 13, and Interleukin 9. , 173-185.
CrossRef29
Esra Birben, Cansın Sackesen, Shamsah Kazani, Gizem Tincer, Cagatay Karaaslan, Berna Durgunsu, Ihsan Gürsel, Michael E. Wechsler, Elliot Israel, Ömer Kalayci. (2011) The effects of an insertion in the 5′UTR of the AMCase on gene expression and pulmonary functions. Respiratory Medicine 105:8, 1160-1169
CrossRef30
Charalampos Papachristou, Carole Ober, Mark Abney. (2011) Genetic variance components estimation for binary traits using multiple related individuals. Genetic Epidemiology 35:5, 291-302
CrossRef31
Tianyi Chen, Weibo Liang, Linbo Gao, Yanyun Wang, Yun Liu, Lushun Zhang, Lin Zhang. (2011) Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population. Human Immunology 72:7, 603-606
CrossRef32
Carole Ober, Tsung-Chieh Yao. (2011) The genetics of asthma and allergic disease: a 21st century perspective. Immunological Reviews 242:1, 10-30
CrossRef33
Stephan Weidinger, Alan D. Irvine. 2011. Genetics of Atopic Dermatitis. , 23.1-23.17.
CrossRef34
M. B. Freidin, E. Yu. Bragina, O. S. Fedorova, I. A. Deev, E. S. Kulikov, L. M. Ogorodova, V. P. Puzyrev. (2011) Genome-wide association study of allergic diseases in Russians of West Siberia. Molecular Biology 45:3, 421-429
CrossRef35
Jason Cunningham, Kaninika Basu, Roger Tavendale, Colin N.A. Palmer, Helen Smith, Somnath Mukhopadhyay. (2011) The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults. Annals of Allergy, Asthma & Immunology 106:5, 381-386
CrossRef36
Ma'en Obeidat, Ian P. Hall. (2011) Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies. British Journal of Pharmacology 163:1, 96-105
CrossRef37
E. Kathryn Miller, Logan Dumitrescu, Chelsea Cupp, Stacy Dorris, Sallee Taylor, Robert Sparks, Diane Fawkes, Virginia Frontiero, Anne M. Rezendes, Colin Marchant, Kathryn M. Edwards, Dana C. Crawford. (2011) Atopy history and the genomics of wheezing after influenza vaccination in children 6–59 months of age. Vaccine 29:18, 3431-3437
CrossRef38
Jian Lei Zheng, Lin Lu, Jian Hu, Rui Yan Zhang, Qi Zhang, Qiu Jin Chen, Wei Feng Shen. (2011) Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population. Cytokine 54:1, 51-55
CrossRef39
Blanca E. Himes, Barbara Klanderman, Isaac S. Kohane, Scott T. Weiss. (2011) Assessing the reproducibility of asthma genome-wide association studies in a general clinical population. Journal of Allergy and Clinical Immunology 127:4, 1067-1069
CrossRef40
Jens Kastrup. (2011) Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?. Immunobiology
CrossRef41
Manuel A R Ferreira, Allan F McRae, Sarah E Medland, Dale R Nyholt, Scott D Gordon, Margaret J Wright, Anjali K Henders, Pamela A Madden, Peter M Visscher, Naomi R Wray, Andrew C Heath, Grant W Montgomery, David L Duffy, Nicholas G Martin. (2011) Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia. European Journal of Human Genetics 19:4, 458-464
CrossRef42
Richard J. Holt, Youming Zhang, Aristea Binia, Anna L. Dixon, Claire Vandiedonck, William O. Cookson, Julian C. Knight, Miriam F. Moffatt. (2011) Allele-specific transcription of the asthma-associated PHD finger protein 11 gene (PHF11) modulated by octamer-binding transcription factor 1 (Oct-1). Journal of Allergy and Clinical Immunology 127:4, 1054-1062.e2
CrossRef43
Philip Stein, Ruhua Yang, Jun Liu, Gregory M. Pastores, Pramod K. Mistry. (2011) Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity. Journal of Inherited Metabolic Disease 34:2, 429-437
CrossRef44
Antonella Lupetti, Mark G. J. de Boer, Paola Erba, Mario Campa, Peter H. Nibbering. (2011) Radiotracers for fungal infection imaging. Medical Mycology 49:S1, S62-S69
CrossRef45
ERICA BÄCKSTRÖM, ANNA HOGMALM, URPO LAPPALAINEN, KRISTINA BRY. (2011) Developmental Stage Is a Major Determinant of Lung Injury in a Murine Model of Bronchopulmonary Dysplasia. Pediatric Research 69:4, 312-318
CrossRef46
Chun Geun Lee, Carla A. Da Silva, Charles S. Dela Cruz, Farida Ahangari, Bing Ma, Min-Jong Kang, Chuan-Hua He, Seyedtaghi Takyar, Jack A. Elias. (2011) Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury. Annual Review of Physiology 73:1, 479-501
CrossRef47
Nicoline M. Korthagen, Coline H.M. van Moorsel, Nicole P. Barlo, Henk J.T. Ruven, Adrian Kruit, Michiel Heron, Jules M.M. van den Bosch, Jan C. Grutters. (2011) Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respiratory Medicine 105:1, 106-113
CrossRef48
Kaspar R Nielsen, Rudi Steffensen, Martin Boegsted, John Baech, Soeren Lundbye-Christensen, Merete L Hetland, Sophine B Krintel, Hans E Johnsen, Mette Nyegaard, Julia S Johansen. (2011) Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects. Arthritis Research & Therapy 13:3, R109
CrossRef49
Alan P. Knutsen, Raymond G. Slavin. (2011) Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis. Clinical and Developmental Immunology 2011, 1-13
CrossRef50
Ramani Anantharaman, Anand Kumar Andiappan, Pallavi Parate Nilkanth, Bani Kaur Suri, De Yun Wang, Fook Tim Chew. (2011) Genome-wide association study identifies PERLD1 as asthma candidate gene. BMC Medical Genetics 12:1, 170
CrossRef51
David Jardine, Mary K. Dahmer, Michael Quasney. 2011. Genomic and Proteomic Medicine in Critical Care. , 1377-1386.
CrossRef52
Daniel T Swarr, Hakon Hakonarson. (2010) Unraveling the complex genetic underpinnings of asthma and allergic disorders. Current Opinion in Allergy and Clinical Immunology 10:5, 434-442
CrossRef53
Moffatt, Miriam F., Gut, Ivo G., Demenais, Florence, Strachan, David P., Bouzigon, Emmanuelle, Heath, Simon, von Mutius, Erika, Farrall, Martin, Lathrop, Mark, Cookson, William O.C.M., . (2010) A Large-Scale, Consortium-Based Genomewide Association Study of Asthma. New England Journal of Medicine 363:13, 1211-1221
Full Text54
William W Busse, Robert F Lemanske, James E Gern. (2010) Role of viral respiratory infections in asthma and asthma exacerbations. The Lancet 376:9743, 826-834
CrossRef55
Benedikte Richter, Anne Roslind, Ulrik Hesse, Jørgen Nordling, Julia Sidenius Johansen, Thomas Horn, Alastair Bierre Hansen. (2010) YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology 57:3, 371-383
CrossRef56
V. V. Radchenko, E. V. Ilnitskaya, V. E. Tretyakov, M. V. Serebryakova, Z. I. Storozheva, T. M. Shuvaeva, V. M. Lipkin. (2010) Identification of a new chitinase-like protein of the YM-1 subgroup in the rat olfactory epithelium. Russian Journal of Bioorganic Chemistry 36:5, 596-602
CrossRef57
Kyle M. Walsh, Michael B. Bracken, William K. Murk, Josephine Hoh, Andrew T. DeWan. (2010) Association between reduced copy-number at T-cell receptor gamma (TCRγ) and childhood allergic asthma: A possible role for somatic mosaicism. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 690:1-2, 89-94
CrossRef58
C. M. Sevin, R. S. Peebles. (2010) Infections and asthma: new insights into old ideas. Clinical & Experimental Allergy 40:8, 1142-1154
CrossRef59
Anders Bruun Mathiasen, Kristoffer Mads Aaris Henningsen, Marina Jurjevna Harutyunyan, Naja Dam Mygind, Jens Kastrup. (2010) YKL-40: a new biomarker in cardiovascular disease?. Biomarkers in Medicine 4:4, 591-600
CrossRef60
Andrea Heinzmann, Markus Brugger, Sibylle Bierbaum, Beena Mailaparambil, Matthias V. Kopp, Konstantin Strauch. (2010) Joint influences of Acidic-Mammalian-Chitinase with Interleukin-4 and Toll-like receptor-10 with Interleukin-13 in the genetics of asthma. Pediatric Allergy and Immunology 21:4p2, e679-e686
CrossRef61
Patrick MA Sleiman, Hakon Hakonarson. (2010) Recent advances in the genetics and genomics of asthma and related traits. Current Opinion in Pediatrics 22:3, 307-312
CrossRef62
Kristoffer Mads Henningsen, Brian Nilsson, Julia S. Johansen, Xu Chen, Steen Pehrson, Jesper Hastrup Svendsen. (2010) Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation. Inflammation Research 59:6, 463-469
CrossRef63
Richard M. Locksley. (2010) Asthma and Allergic Inflammation. Cell 140:6, 777-783
CrossRef64
Hsiang-Cheng Chen, Virginia Byers Kraus, Yi-Ju Li, Sarah Nelson, Carol Haynes, Jessica Johnson, Thomas Stabler, Elizabeth R. Hauser, Simon G. Gregory, William E. Kraus, Svati H. Shah. (2010) Genome-wide linkage analysis of quantitative biomarker traits of osteoarthritis in a large, multigenerational extended family. Arthritis & Rheumatism 62:3, 781-790
CrossRef65
Ann Chen Wu, Jessica Lasky-Su, Christine A. Rogers, Barbara J. Klanderman, Augusto Litonjua. (2010) Polymorphisms of chitinases are not associated with asthma. Journal of Allergy and Clinical Immunology 125:3, 754-757.e2
CrossRef66
Joan Reibman, Mengling Liu. (2010) Genetics and Asthma Disease Susceptibility in the US Latino Population. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:2, 140-148
CrossRef67
Rasika A. Mathias, Audrey V. Grant, Nicholas Rafaels, Tracey Hand, Li Gao, Candelaria Vergara, Yuhjung J. Tsai, Mao Yang, Monica Campbell, Cassandra Foster, Peisong Gao, A. Togias, Nadia N. Hansel, Gregory Diette, N. Franklin Adkinson, Mark C. Liu, Mezbah Faruque, Georgia M. Dunston, Harold R. Watson, Michael B. Bracken, Josephine Hoh, Pissamai Maul, Trevor Maul, Anne E. Jedlicka, Tanda Murray, Jacqueline B. Hetmanski, Roxann Ashworth, Chrissie M. Ongaco, Kurt N. Hetrick, Kimberly F. Doheny, Elizabeth W. Pugh, Charles N. Rotimi, Jean Ford, Celeste Eng, Esteban G. Burchard, Patrick M.A. Sleiman, Hakon Hakonarson, Erick Forno, Benjamin A. Raby, Scott T. Weiss, Alan F. Scott, Michael Kabesch, Liming Liang, Gonçalo Abecasis, Miriam F. Moffatt, William O.C. Cookson, Ingo Ruczinski, Terri H. Beaty, Kathleen C. Barnes. (2010) A genome-wide association study on African-ancestry populations for asthma. Journal of Allergy and Clinical Immunology 125:2, 336-346.e4
CrossRef68
Patrick Murphy, Tobias Hillman, Karalasingam Rajakulasingam. (2010) Therapeutic targets for persistent airway inflammation in refractory asthma. Biomedicine & Pharmacotherapy 64:2, 140-145
CrossRef69
Emma E. Thompson, Ying Sun, Dan Nicolae, Carole Ober. (2010) Shades of gray: a comparison of linkage disequilibrium between Hutterites and Europeans. Genetic Epidemiology 34:2, 133-139
CrossRef70
M. Kabesch. (2010) Asthmagenetik 2010. Monatsschrift Kinderheilkunde 158:2, 129-136
CrossRef71
Xingnan Li, Timothy D. Howard, Siqun L. Zheng, Tmirah Haselkorn, Stephen P. Peters, Deborah A. Meyers, Eugene R. Bleecker. (2010) Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. Journal of Allergy and Clinical Immunology 125:2, 328-335.e11
CrossRef72
Chun Geun Lee, Jack A Elias. (2010) Role of breast regression protein-39/YKL-40 in asthma and allergic responses. Allergy, Asthma and Immunology Research 2:1, 20
CrossRef73
James H. Diaz. (2010) Mite-Transmitted Dermatoses and Infectious Diseases in Returning Travelers. Journal of Travel Medicine 17:1, 21-31
CrossRef74
Jian-Feng Meng, Lanny J Rosenwasser. (2010) Unraveling the Genetic Basis of Asthma and Allergic Diseases. Allergy, Asthma and Immunology Research 2:4, 215
CrossRef75
Yoshiko Ogawa, William J Calhoun. (2010) Phenotypic characterization of severe asthma. Current Opinion in Pulmonary Medicine 16:1, 48-54
CrossRef76
ALIYA N. HUSAIN. 2010. The Lung. , 677-737.
CrossRef77
Daniel Arnold, Bridgette L. Jones. (2009) Personalized medicine: A pediatric perspective. Current Allergy and Asthma Reports 9:6, 426-432
CrossRef78
Peter S. Marshall, Jennifer Possick, Geoffrey L. Chupp. (2009) Intensive Care Unit Management of Status Asthmaticus. Clinical Pulmonary Medicine 16:6, 293-301
CrossRef79
Noriyuki Hattori, Shigeto Oda, Tomohito Sadahiro, Masataka Nakamura, Ryuzo Abe, Koichiro Shinozaki, Fumio Nomura, Takeshi Tomonaga, Kazuyuki Matsushita, Yoshio Kodera, Kazuyuki Sogawa, Mamoru Satoh, Hiroyuki Hirasawa. (2009) YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS. Shock 32:4, 393-400
CrossRef80
Stefano Guerra. (2009) Asthma and chronic obstructive pulmonary disease. Current Opinion in Allergy and Clinical Immunology 9:5, 409-416
CrossRef81
Carole Ober, Geoffrey L Chupp. (2009) The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Current Opinion in Allergy and Clinical Immunology 9:5, 401-408
CrossRef82
Blandine Boisselier, Yannick Marie, Soufiane El Hallani, Gentian Kaloshi, Anton Iershov, Vadym Kavsan, Dimitri Psimaras, Joëlle Thillet, Khe Hoang-Xuan, Jean-Yves Delattre, Marc Sanson. (2009) No association of (−131C→G) variant of CHI3L1 gene with risk of glioblastoma and prognosis. Journal of Neuro-Oncology 94:2, 169-172
CrossRef83
Julia S Johansen, Nicolai A Schultz, Benny V Jensen. (2009) Plasma YKL-40: a potential new cancer biomarker?. Future Oncology 5:7, 1065-1082
CrossRef84
B. Laurel Elder, Larry G. Arlian, Marjorie S. Morgan. (2009) Modulation of human dermal microvascular endothelial cells by Sarcoptes scabiei in combination with proinflammatory cytokines, histamine, and lipid-derived biologic mediators. Cytokine 47:2, 103-111
CrossRef85
Emily J. Swindle, Jane E. Collins, Donna E. Davies. (2009) Breakdown in epithelial barrier function in patients with asthma: Identification of novel therapeutic approaches. Journal of Allergy and Clinical Immunology 124:1, 23-34
CrossRef86
Patrick MA Sleiman, Hakon Hakonarson. (2009) Pharmacogenetics and functional genomics in asthma. Personalized Medicine 6:4, 409-416
CrossRef87
A. E. Murmann, D. F. Conrad, H. Mashek, C. A. Curtis, R. I. Nicolae, C. Ober, S. Schwartz. (2009) Inverted duplications on acentric markers: mechanism of formation. Human Molecular Genetics 18:12, 2241-2256
CrossRef88
Kazuo Yamada, Eiji Hattori, Yoshimi Iwayama, Tomoko Toyota, Tetsuo Ohnishi, Yasuhide Iwata, Kenji J. Tsuchiya, Genichi Sugihara, Mitsuru Kikuchi, Yuji Okazaki, Takeo Yoshikawa. (2009) Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B:4, 508-514
CrossRef89
Elena S. Gusareva, Elena Ju. Bragina, Svetlana N. Buinova, Boris A. Chernyak, Valery P. Puzyrev, Ludmila M. Ogorodova, Marie Lipoldová. (2009) Chromosome 12q24.3 controls sensitization to cat allergen in patients with asthma from Siberia, Russia. Immunology Letters 125:1, 1-6
CrossRef90
C. G. Lee, D. Hartl, G. R. Lee, B. Koller, H. Matsuura, C. A. Da Silva, M. H. Sohn, L. Cohn, R. J. Homer, A. A. Kozhich, A. Humbles, J. Kearley, A. Coyle, G. Chupp, J. Reed, R. A. Flavell, J. A. Elias. (2009) Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. Journal of Experimental Medicine 206:5, 1149-1166
CrossRef91
Blanca E. Himes, Gary M. Hunninghake, James W. Baurley, Nicholas M. Rafaels, Patrick Sleiman, David P. Strachan, Jemma B. Wilk, Saffron A.G. Willis-Owen, Barbara Klanderman, Jessica Lasky-Su, Ross Lazarus, Amy J. Murphy, Manuel E. Soto-Quiros, Lydiana Avila, Terri Beaty, Rasika A. Mathias, Ingo Ruczinski, Kathleen C. Barnes, Juan C. Celedón, William O.C. Cookson, W. James Gauderman, Frank D. Gilliland, Hakon Hakonarson, Christoph Lange, Miriam F. Moffatt, George T. O'Connor, Benjamin A. Raby, Edwin K. Silverman, Scott T. Weiss. (2009) Genome-wide Association Analysis Identifies PDE4D as an Asthma-Susceptibility Gene. The American Journal of Human Genetics 84:5, 581-593
CrossRef92
T. Lencz, R. H. Lipsky, P. DeRosse, K. E. Burdick, J. M. Kane, A. K. Malhotra. (2009) Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. The British Journal of Psychiatry 194:4, 313-318
CrossRef93
Peter N Le Souëf. (2009) Gene–environmental interaction in the development of atopic asthma: new developments. Current Opinion in Allergy and Clinical Immunology 9:2, 123-127
CrossRef94
Marie-Luise Berres, Sven Papen, Katrin Pauels, Petra Schmitz, Mirko Moreno Zaldivar, Claus Hellerbrand, Tobias Mueller, Thomas Berg, Ralf Weiskirchen, Christian Trautwein, Hermann E. Wasmuth. (2009) A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. Journal of Hepatology 50:2, 370-376
CrossRef95
Dominik Hartl, Chun G Lee, Carla A Da Silva, Geoffrey L Chupp, Jack A Elias. (2009) Novel biomarkers in asthma: chemokines and chitinase-like proteins. Current Opinion in Allergy and Clinical Immunology 9:1, 60-66
CrossRef96
Yusuke Nakamura. (2009) DNA variations in human and medical genetics: 25 years of my experience. Journal of Human Genetics 54:1, 1-8
CrossRef97
Elena S. Gusareva, Helena Havelková, Hana Blažková, Marcela Kosařová, Petr Kučera, Vlastimil Král, Daria Salyakina, Bertram Müller-Myhsok, Marie Lipoldová. (2009) Mouse to human comparative genetics reveals a novel immunoglobulin E-controlling locus on Hsa8q12. Immunogenetics 61:1, 15-25
CrossRef98
Eva Halapi, Unnur Steina Bjornsdottir. (2009) Overview on the current status of asthma genetics. The Clinical Respiratory Journal 3:1, 2-7
CrossRef99
Saffron A. G. Willis-Owen, William O. Cookson, Miriam F. Moffatt. (2009) Genome-wide association studies in the genetics of asthma. Current Allergy and Asthma Reports 9:1, 3-9
CrossRef100
Chun Geun Lee. (2009) Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling. Yonsei Medical Journal 50:1, 22
CrossRef101
Dermot P.B. McGovern, Kent D. Taylor, Carol Landers, Carrie Derkowski, Deb Dutridge, Marla Dubinsky, Andy Ippoliti, Eric Vasiliauskas, Ling Mei, Emebet Mengesha, Lily King, Sheila Pressman, Stephan R. Targan, Jerome I. Rotter. (2009) MAGI2 genetic variation and inflammatory bowel disease. Inflammatory Bowel Diseases 15:1, 75-83
CrossRef102
Chun Geun Lee, Carla A Da Silva, Jae-Young Lee, Dominik Hartl, Jack A Elias. (2008) Chitin regulation of immune responses: an old molecule with new roles. Current Opinion in Immunology 20:6, 684-689
CrossRef103
A. Labbé. (2008) Indicateurs prédictifs dans l’asthme de l’enfant. Revue Française d'Allergologie et d'Immunologie Clinique 48:8, 539-542
CrossRef104
Max A. Seibold, Samantha Donnelly, Margaret Solon, Anh Innes, Prescott G. Woodruff, Rolf G. Boot, Esteban González Burchard, John V. Fahy. (2008) Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. Journal of Allergy and Clinical Immunology 122:5, 944-950.e3
CrossRef105
Hidefumi Waki, Sabine S. Gouraud, Masanobu Maeda, Julian F.R. Paton. (2008) Specific inflammatory condition in nucleus tractus solitarii of the SHR: Novel insight for neurogenic hypertension?. Autonomic Neuroscience 142:1-2, 25-31
CrossRef106
Jayant M. Pinto, M Geoffrey Hayes, Daniel Schneider, Robert M. Naclerio, Carole Ober. (2008) A Genomewide Screen for Chronic Rhinosinusitis Genes Identifies a Locus on Chromosome 7q. The Laryngoscope 118:11, 2067-2072
CrossRef107
Annette Osei-Kumah, Nicolette Hodyl, Vicki L Clifton. (2008) Proteomics in asthma. Expert Review of Clinical Immunology 4:6, 713-721
CrossRef108
Hidefumi Waki, Sabine S. Gouraud, Masanobu Maeda, Julian F.R. Paton. (2008) Gene expression profiles of major cytokines in the nucleus tractus solitarii of the spontaneously hypertensive rat. Autonomic Neuroscience 142:1-2, 40-44
CrossRef109
Miriam F Moffatt. (2008) Genes in asthma: new genes and new ways. Current Opinion in Allergy and Clinical Immunology 8:5, 411-417
CrossRef110
Moffatt, Miriam F., Cookson, William O.C.M., . (2008) Asthma and Chitinases. New England Journal of Medicine 358:16, 1725-1726
Full Text
